from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1955/higB

LFCtreatmentdescriptionclass of inhibitor

2.308

Amikacinug/mL Amikacintranslation

1.634

Cap5-10ug/mL Capreomycintranslation

1.942

Rox10-50 ug/mL Roxithromycintranslation

1.571

SM2-5 ug/mL Streptomycintranslation

2.001

Tet5-10 ug/mL Tetracyclinetranslation

-0.581

Rif0.2-5ug/mL Rifampicintranscription

-0.640

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.224

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.753

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.430

CPZ10-50 ug/mL Chlorpromazinerespiration

0.613

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.400

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.423

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.935

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.541

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.327

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.066

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.079

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.160

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.020

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.461

KCN5-20 ug/mL Potassium cyaniderespiration

-0.417

NaN30.2-2 mM Sodium aziderespiration

0.711

Nigericin50 uM Nigericinrespiration

0.164

TRC10-150 ug/mL Triclosanrespiration

0.777

TRZ10-25 ug/mL Thioridazinerespiration

3.341

Valinomycin0.5-10 uM Valinomycinrespiration

-1.105

ZnSO42 mM ZnSO4respiration

1.554

menadione6-10 ug/mL Menadionerespiration

-0.297

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.287

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.181

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.659

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.879

NRP_1Non-replicating persistence stage 1dosRassociated

-0.497

Amp0.2mg/mL AmpicillincellWall

-0.449

Cephalexin20-100 ug/mL CephalexincellWall

-0.358

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.569

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.445

EMB10-20 ug/mL EthambutolcellWall

-0.579

Eta12-40 ug/mL EthionamidecellWall

-0.806

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.460

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.480

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.964

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.754

BZA0.12 mg/mL BenzamidearomaticAmides

-0.554

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.473

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.472

H2O24 mM hydrogen peroxideDNAdamaging

0.407

Levo10 ug/mL LevofloxacinDNAdamaging

-0.193

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.506

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.150

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.173

UVUV-irradiationDNAdamaging

0.941

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.575

Antimycin12.5-50 ug/mL Antimycin A?

-0.551

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.488

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.505

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.460

PA8240.2-2 ug/mL PA-824?

0.602

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.659

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.084

Verapamil50 uM Verapamil?

-0.343

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.156

methoxatin10-20 ug/mL Methoxatin?